Abstract
Plexiform neurofibroma (PNF) is a typical feature of neurofibromatosis 1 (NF1). About 10% of patients with NF1 develop malignant peripheral nerve-sheath tumours (MPNST), usually arising from PNF, and this is the major cause of poor survival. A better prognosis can be achieved if the tumours are diagnosed at an early stage. Our objective was to establish MRI criteria for MPNST and to test their usefulness in detecting early malignant change in PNF. MRI was performed on 50 patients with NF1 and nerve-sheath tumours, of whom seven had atypical pain, tumour growth or neurological deficits indicative of malignancy; the other 43 were asymptomatic. On MRI all seven symptomatic patients had inhomogeneous lesions, due to necrosis and haemorrhage and patchy contrast enhancement. In one patient, the multiplicity of confluent tumours with inhomogeneous areas in addition to central lesions did not allow exclusion of malignancy. Only three of the 43 asymptomatic patients had comparable changes; the other 40 patients had tumours being of relatively homogeneous structure on T1- and T2-weighted images before and after contrast enhancement. All three asymptomatic patients with inhomogeneous lesions were shown to have MPNST.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Huson SM, Harper PS, Compston DAS (1988) Von Recklinghausen neurofibromatosis – a clinical and population study in South-East Wales. Brain 111: 1355–1381
Tonsgard JH, Kwak SM, Short P, Dachman AH (1988) CT imaging in adults with neurofibromatosis 1. Frequent asymptomatic plexiform lesions. Neurology 50: 1755–1760
McGaughran JM, Harris DI, Donnai D, et al (1999) A clinical study of type 1 neurofibromatosis in north west England. J Med Genet 36: 197–203
Rasmussen SA, Quanhe Y, Friedman JM (2001) Mortality in neurofibromatosis 1: an analysis using U.S. death certificates. Am J Hum Genet 68: 1110–1118
Ferner RE, Gutmann D (2002) International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis 1. Cancer Res 62: 1573–777
Leroy K, Dumas V, Martin-García N, et al (2001) Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1. Arch Dermatol 137: 908–913
King AA, DeBaun MR, Riccardi VM, Gutmann DH (2000) Malignant peripheral nerve sheath tumors in neurofibromatosis 1. Am J Med Genet 93: 388–392
Wong WW, Hirose T, Scheithauer BW, Schild SE, Gunderson LL (1998) Malignant peripheral nerve sheath tumor: analysis of treatment outcome. Int J Radiat Oncol Biol Phys 42: 351–360
Kluwe L, Friedrich RE, Korf B, Fahsold R, Mautner VF (2002) NF1 mutations in neurofibromatosis 1 patients with plexiform neurofibromas. Hum Mut 19: 309
Cerofolini E, Landi A, DeSantis G, Maiorana A, Canossi G, Romagnoli R (1991) MR of benign peripheral nerve sheath tumors. J Comput Assist Tomogr 15: 593–597
Bhargava R, Parham DM, Lasater OE, Chari RS, Chen G, Fletcher BD (1997) MR imaging differentiation of benign and malignant peripheral nerve sheath tumors: use of the target sign. Pediatr Radiol 27: 124–129
Levine E, Huntrakoon M, Wetzel LH (1987) Malignant nerve-sheath neoplasms in neurofibromatosis: distinction from benign tumors by using imaging techniques. Am J Roentgenol 149: 1059–1064
Acknowledgements
This study was supported by Deutsche Krebshilfe Grant No. 70-2794-De 1 and the Hamburger Stiftung zur Förderung der Krebsbekämpfung No. 161.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mautner, V.F., Friedrich, R.E., von Deimling, A. et al. Malignant peripheral nerve sheath tumours in neurofibromatosis type 1: MRI supports the diagnosis of malignant plexiform neurofibroma. Neuroradiology 45, 618–625 (2003). https://doi.org/10.1007/s00234-003-0964-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00234-003-0964-6